Ming-Chieh Tsai, Cheng-Tzu Hsieh, Hsin-Yin Hsu, Tzu-Lin Yeh, Wen-Chung Lee, Chun-Ju Chiang, Bo-Yu Hsiao, Jing-Rong Jhuang, Wen-Hsuan Tsai, Shih-Ping Cheng, Chao-Liang Chou, Chun-Chuan Lee, Sung-Chen Liu, Po-Jung Tseng, Kuo-Liong Chien
Treatment with levothyroxine and radioiodine contribute alternative cardiovascular function in adults with thyroid cancer. The risks of long-term cardiovascular conditions among thyroid cancer patients is unknown. This study aimed to compare the incidence of coronary heart disease (CHD), ischemic stroke (IS), and atrial fibrillation (AF) among adults with thyroid cancer with that of the general population, especially when stratified by age (< 65 and ≥ 65 years old). This observational cohort study enrolled patients between January 1, 2011 and December 31, 2016 with a follow-up until December 31, 2018...
November 2, 2022: Scientific Reports